Contact

Wide Anchor 54 Home About Services Safety Checklist Risk & Contraindications Global Regulatory Landscape Contact Independent resource · safety before claims Global Ibogaine Therapy Standards: A Checklist A plainspoken framework for evaluating medical screening, monitoring, emergency readiness, legal context, and patient protections around an investigational, high-risk intervention. A checklist is not a promise of safety; it is a way to ask whether essential safeguards can be demonstrated. Ibogaine therapy remains investigational for most indications. Any claim of “safe ibogaine” without physician-led screening, repeat ECGs, continuous cardiac monitoring, electrolyte management, emergency capability, medication controls, and a hospital-transfer pathway is not evidence-based. 01 · Scope Understanding ibogaine therapy Potential should never be separated from uncertainty, legal context, or a full accounting of risk. Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of the Tabernanthe iboga plant, historically used in traditional spiritual practices in West Africa. Background on Gabonese context and Bwiti practice matters because cross-cultural considerations should not disappear when ibogaine therapy is discussed in clinical settings. Research suggests ibogaine may interrupt opioid withdrawal symptoms and reduce cravings for opioids, alcohol, and stimulants, sometimes after a single ibogaine treatment. These are promising signals rather than proof of a cure. The National Library of Medicine review of ibogaine describes both the interest in addiction treatment and the substantial safety concerns that limit simple conclusions. The substance is thought to influence dopamine pathways, serotonin reuptake, opioid receptors, and the central nervous system. Its active metabolite, noribogaine, may have a prolonged half-life of up to 36 hours; the discussion of noribogaine’s duration helps explain why observation cannot end when the acute expe

Contact

A considered way to stay in touch.